
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Recipient : Hovione
Deal Size : Undisclosed
Deal Type : Partnership
Hovione & Firstgene Partner on HCC Targeted Therapy
Details : Hovione will grant Firstgene an exclusive license to its proprietary novel targeted Adeno-Associated Virus (AAV)-Like particle technology for the treatment of HCC.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 06, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Recipient : Hovione
Deal Size : Undisclosed
Deal Type : Partnership
